BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kachare SD, Liner KR, Vohra NA, Zervos EE, Hickey T, Fitzgerald TL. Assessment of health care cost for complex surgical patients: review of cost, re-imbursement and revenue involved in pancreatic surgery at a high-volume academic medical centre. HPB (Oxford) 2015;17:311-7. [PMID: 25298015 DOI: 10.1111/hpb.12349] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Goyert N, Eeson G, Kagedan DJ, Behman R, Lemke M, Hallet J, Mittmann N, Law C, Karanicolas PJ, Coburn NG. Pasireotide for the Prevention of Pancreatic Fistula Following Pancreaticoduodenectomy: A Cost-effectiveness Analysis. Ann Surg. 2017;265:2-10. [PMID: 27537539 DOI: 10.1097/sla.0000000000001889] [Cited by in Crossref: 23] [Cited by in F6Publishing: 5] [Article Influence: 4.6] [Reference Citation Analysis]
2 Gani F, Hundt J, Makary MA, Haider AH, Zogg CK, Pawlik TM. Financial Impact of Postoperative Complication Following Hepato-Pancreatico-Biliary Surgery for Cancer. Ann Surg Oncol 2016;23:1064-70. [DOI: 10.1245/s10434-015-5042-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
3 Abbott DE, Sutton JM, Jernigan PL, Chang A, Frye P, Shah SA, Schauer DP, Eckman MH, Ahmad SA, Sussman JJ. Prophylactic pasireotide administration following pancreatic resection reduces cost while improving outcomes: Cost Effectiveness of Pasireotide. J Surg Oncol 2016;113:784-8. [DOI: 10.1002/jso.24239] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
4 Rosemurgy A, Ross S, Bourdeau T, Jacob K, Thomas J, Przetocki V, Luberice K, Sucandy I. Cost Analysis of Pancreaticoduodenectomy at a High-Volume Robotic Hepatopancreaticobiliary Surgery Program. J Am Coll Surg 2021;232:461-9. [PMID: 33581292 DOI: 10.1016/j.jamcollsurg.2020.12.062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Koolmees D, Ramkumar PN, Hessburg L, Guo E, Bernstein DN, Makhni EC. Time-Driven Activity-based Costing for Anterior Cruciate Ligament Reconstruction: A Comparison to Traditional Accounting Methods. Arthrosc Sports Med Rehabil 2021;3:e39-45. [PMID: 33615246 DOI: 10.1016/j.asmr.2020.08.006] [Reference Citation Analysis]
6 Rivera D. Emerging Role for 7T MRI and Metabolic Imaging for Pancreatic and Liver Cancer. Metabolites 2022;12:409. [DOI: 10.3390/metabo12050409] [Reference Citation Analysis]
7 Späth C, Srinivasa S, Walsh M, Singh P, Rodgers M, Koea J. Role of post-operative serum C-reactive protein levels as a predictor of complications in upper gastrointestinal surgery.ANZ J Surg. 2019;89:74-78. [PMID: 30207031 DOI: 10.1111/ans.14789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Brozzetti S, Bini S, De Lio N, Lombardo C, Boggi U. Surgical-only treatment of pancreatic and extra-pancreatic metastases from renal cell carcinoma - quality of life and survival analysis. BMC Surg 2020;20:101. [PMID: 32404091 DOI: 10.1186/s12893-020-00757-0] [Reference Citation Analysis]
9 El Amrani M, Fulbert M, Lenne X, Clément G, Drumez E, Pruvot F, Truant S. Do complications following pancreatic resections impact hospital costs in France: Medico-economic study on 127 patients. Journal of Visceral Surgery 2018;155:465-70. [DOI: 10.1016/j.jviscsurg.2018.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Guyton RL, Mosquera C, Spaniolas K, Fitzgerald TL. Association of Increasing Frailty with Detrimental Outcomes after Pancreatic Resection. The American Surgeon 2018;84:512-9. [DOI: 10.1177/000313481808400423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
11 Wang Z, Duan Y, Zhang J, Lv Y, Wu S, Cheng M, Bhagavathula AS, Aldhaleei WA, Clark C, Huo Z. Preoperative antiviral therapy and microvascular invasion in hepatitis B virus-related hepatocellular carcinoma: A meta-analysis. Eur J Pharmacol 2020;883:173382. [PMID: 32693099 DOI: 10.1016/j.ejphar.2020.173382] [Reference Citation Analysis]
12 Andreou A, Aeschbacher P, Candinas D, Gloor B. The Impact of Patient Age ≥80 Years on Postoperative Outcomes and Treatment Costs Following Pancreatic Surgery. J Clin Med 2021;10:696. [PMID: 33578965 DOI: 10.3390/jcm10040696] [Reference Citation Analysis]
13 Vidri RJ, Mohamed A, Mack JD, MacGillivray D, Fitzgerald TL. The Cost of Frailty in Complex Gastrointestinal Surgery. Am Surg 2022;:31348221086807. [PMID: 35392683 DOI: 10.1177/00031348221086807] [Reference Citation Analysis]